{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:59Z","timestamp":1794473399616,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute upper gastrointestinal bleeding (UGIB) in acute coronary syndrome (ACS) patients are not uncommon, particularly under dual antiplatelet therapy (DAPT). The efficiency and safety of early endoscopy (EE) for UGIB in these patients needs to be elucidated. This multicenter randomized controlled trial randomized recent ACS patients presenting acute UGIB to non-EE and EE groups. All eligible patients received intravenous proton pump inhibitor therapy. Those in EE group underwent therapeutic endoscopy within 24\u00a0h after bleeding. The data regarding efficacy and safety of EE were analyzed. It was early terminated because the UGIB rate was lower than expected and interim analysis was done. In total, 43 patients were randomized to non-EE (21 patients) and EE (22 patients) groups. The failure rate of control hemorrhage (intention-to-treat [ITT] 4.55% vs. 23.81%, p\u2009&lt;\u20090.001; per-protocol [PP] 0% vs. 4.55%, p\u2009=\u20090.058) and 3-day rebleeding rate (ITT 4.55% vs. 28.57%, p\u2009=\u20090.033; PP 0% vs. 21.05%, p\u2009=\u20090.027) were lower in EE than non-EE group. The mortality, minor and major complication rates were not different between two groups. Male patients were at higher risk of minor and major complications after EE with OR (95% CI) of 3.50 (1.15\u201310.63) and 4.25 (1.43\u201312.63), respectively. In multivariate analysis, EE was associated with lower needs for blood transfusion (HR 0.13, 95% CI 0.02\u20130.98). Among patients who discontinued DAPT during acute UGIB, a higher risk (OR 5.25, 95% CI 1.21\u201322.74) of coronary artery stent re-thrombosis within 6\u00a0months was noticed. EE for acute UGIB in recent ACS patients has higher rate of bleeding control, lower 3-day rebleeding rate and lower needs for blood transfusion, but more complications in male patients. Further enrollment is mandatory to avoid bias from small sample size (ClinicalTrial.gov Number NCT02618980, registration date 02\/12\/2015).<\/jats:p>","DOI":"10.1038\/s41598-022-09911-5","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T12:07:49Z","timestamp":1649246869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Chen-Shuan","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Nien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chuang","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Kuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Hsi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"issue":"1742","key":"9911_CR1","first-page":"15","volume":"255","author":"AD Hopper","year":"2011","unstructured":"Hopper, A. D. & Sanders, D. S. Upper GI bleeding requires prompt investigation. Practitioner 255(1742), 15\u201319 (2011).","journal-title":"Practitioner"},{"issue":"3","key":"9911_CR2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/gut.38.3.316","volume":"38","author":"TA Rockall","year":"1996","unstructured":"Rockall, T. A. et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38(3), 316\u2013321 (1996).","journal-title":"Gut"},{"issue":"7","key":"9911_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-150-7-200904070-00105","volume":"150","author":"JJ Sung","year":"2009","unstructured":"Sung, J. J. et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: A randomized trial. Ann. Intern. Med. 150(7), 455\u2013464 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"6999","key":"9911_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bmj.311.6999.222","volume":"311","author":"TA Rockall","year":"1995","unstructured":"Rockall, T. A. et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 311(6999), 222\u2013226 (1995).","journal-title":"BMJ"},{"issue":"10","key":"9911_CR5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1055\/s-0030-1256664","volume":"43","author":"PN Meier","year":"2011","unstructured":"Meier, P. N. Complications in gastrointestinal endoscopy: A summary at the first international symposium in Hannover 2009. Endoscopy 43(10), 892\u2013896 (2011).","journal-title":"Endoscopy"},{"issue":"7","key":"9911_CR6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/01.WNL.0000086817.54076.EB","volume":"61","author":"DJ Blacker","year":"2003","unstructured":"Blacker, D. J., Wijdicks, E. F. & McClelland, R. L. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 61(7), 964\u2013968 (2003).","journal-title":"Neurology"},{"issue":"5","key":"9911_CR7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2013.04.055","volume":"112","author":"JS Berger","year":"2013","unstructured":"Berger, J. S. Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes. Am. J. Cardiol. 112(5), 737\u2013745 (2013).","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"9911_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.amjcard.2017.10.035","volume":"121","author":"SU Khan","year":"2018","unstructured":"Khan, S. U. et al. Meta-analysis of the safety and efficacy of the oral anticoagulant agents (apixaban, rivaroxaban, dabigatran) in patients with acute coronary syndrome. Am. J. Cardiol. 121(3), 301\u2013307 (2018).","journal-title":"Am. J. Cardiol."},{"issue":"13","key":"9911_CR9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","volume":"318","author":"SH Chang","year":"2017","unstructured":"Chang, S. H. et al. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 318(13), 1250\u20131259 (2017).","journal-title":"JAMA"},{"issue":"7270","key":"9911_CR10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","volume":"321","author":"S Derry","year":"2000","unstructured":"Derry, S. & Loke, Y. K. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. BMJ 321(7270), 1183\u20131187 (2000).","journal-title":"BMJ"},{"issue":"9","key":"9911_CR11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.12483","volume":"38","author":"CC Lin","year":"2013","unstructured":"Lin, C. C. et al. Risk factors of gastrointestinal bleeding in clopidogrel users: A nationwide population-based study. Aliment Pharmacol. Ther. 38(9), 1119\u20131128 (2013).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"9","key":"9911_CR12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02649.x","volume":"22","author":"D Yeomans","year":"2005","unstructured":"Yeomans, D. et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol. Ther. 22(9), 795\u2013801 (2005).","journal-title":"Aliment Pharmacol. Ther."},{"key":"9911_CR13","doi-asserted-by":"publisher","first-page":"9564529","DOI":"10.1155\/2016\/9564529","volume":"2016","author":"A Dorreen","year":"2016","unstructured":"Dorreen, A. et al. Safety of digestive endoscopy following acute coronary syndrome: A systematic review. Can. J. Gastroenterol. Hepatol. 2016, 9564529. https:\/\/doi.org\/10.1155\/2016\/9564529 (2016).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"9911_CR14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.01.011","volume":"66","author":"G ErtlT","year":"2005","unstructured":"ErtlT, G. & Frantz, S. Healing after myocardial infarction. Cardiovasc. Res. 66, 22\u201332 (2005).","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"9911_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0735-1097(01)01319-5","volume":"38","author":"P Gaudron","year":"2001","unstructured":"Gaudron, P. et al. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: Their inter-relation and prognostic impact. J. Am. Coll. Cardiol. 38(1), 33\u201340 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2 Suppl 1","key":"9911_CR16","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 39(2 Suppl 1), S1\u2013S266 (2002).","journal-title":"Am. J. Kidney Dis."},{"issue":"16","key":"9911_CR17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMoa065703","volume":"356","author":"JY Lau","year":"2007","unstructured":"Lau, J. Y. et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N. Engl. J. Med. 356(16), 1631\u20131640 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"9911_CR18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus, W. A. et al. APACHE II: A severity of disease classification system. Crit. Care Med. 13(10), 818\u2013829 (1985).","journal-title":"Crit. Care Med."},{"key":"9911_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM199409153311107","volume":"331","author":"L Laine","year":"1994","unstructured":"Laine, L. & Peterson, W. L. Bleeding peptic ulcer. N. Engl. J. Med. 331, 717\u2013727 (1994).","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"9911_CR20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199912023412306","volume":"341","author":"DJ Van","year":"1999","unstructured":"Van, D. J. & Brugge, W. R. Endoscopy of the upper gastrointestinal tract. N. Engl. J. Med. 341(23), 1738\u20131748 (1999).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"9911_CR21","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.amjcard.2011.07.039","volume":"108","author":"YL Chen","year":"2011","unstructured":"Chen, Y. L. et al. Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy. Am. J. Cardiol. 108(12), 1704\u20131709 (2011).","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"9911_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijcard.2010.12.081","volume":"157","author":"A Shalev","year":"2012","unstructured":"Shalev, A. et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int. J. Cardiol. 157(3), 386\u2013390 (2012).","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"9911_CR23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf, S. et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345(7), 494\u2013502 (2001).","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"9911_CR24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","volume":"54","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky, E. et al. Gastrointestinal bleeding in patients with acute coronary syndromes: Incidence, predictors, and clinical implications: Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Coll. Cardiol. 54(14), 1293\u20131302 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9238","key":"9911_CR25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(00)02816-6","volume":"356","author":"O Blatchford","year":"2000","unstructured":"Blatchford, O., Murray, W. R. & Blatchford, M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 356(9238), 1318\u20131321 (2000).","journal-title":"Lancet"},{"issue":"19","key":"9911_CR26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.162.19.2197","volume":"162","author":"SM Weisman","year":"2002","unstructured":"Weisman, S. M. & Graham, D. Y. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch. Intern. Med. 162(19), 2197\u20132202 (2002).","journal-title":"Arch. Intern. Med."},{"issue":"7328","key":"9911_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"AT Collaboration","year":"2002","unstructured":"AT Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7328), 71\u201386 (2002).","journal-title":"BMJ"},{"issue":"6","key":"9911_CR28","first-page":"227","volume":"20","author":"A Chowdhury","year":"2001","unstructured":"Chowdhury, A. et al. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: A prospective, endoscopic study. Indian J. Gastroenterol. 20(6), 227\u2013229 (2001).","journal-title":"Indian J. Gastroenterol."},{"issue":"9038","key":"9911_CR29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CS Committee","year":"1996","unstructured":"CS Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038), 1329\u20131339 (1996).","journal-title":"Lancet"},{"issue":"11","key":"9911_CR30","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1073\/pnas.111150798","volume":"98","author":"L Ma","year":"2001","unstructured":"Ma, L. et al. Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release. Proc. Natl. Acad. Sci. U.S.A. 98(11), 6470\u20136475 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"9911_CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","volume":"352","author":"FK Chan","year":"2005","unstructured":"Chan, F. K. et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N. Engl. J. Med. 352(3), 238\u2013244 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"9911_CR32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2036.2003.01693.x","volume":"18","author":"FH Ng","year":"2003","unstructured":"Ng, F. H. et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol. Ther. 18(4), 443\u2013449 (2003).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"3","key":"9911_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2012\/841792","volume":"26","author":"F Al-Ebrahim","year":"2012","unstructured":"Al-Ebrahim, F. et al. Safety of esophagogastroduodenoscopy within 30 days of myocardial infarction: A retrospective cohort study from a Canadian tertiary centre. Can. J. Gastroenterol. 26(3), 151\u2013154 (2012).","journal-title":"Can. J. Gastroenterol."},{"issue":"3","key":"9911_CR34","first-page":"344","volume":"88","author":"MS Cappell","year":"1993","unstructured":"Cappell, M. S. The safety and clinical utility of esophagogastroduodenoscopy for acute gastrointestinal bleeding after myocardial infarction: A six-year study of 42 endoscopies in 34 consecutive patients at two university teaching hospitals. Am. J. Gastroenterol. 88(3), 344\u2013350 (1993).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"9911_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(98)00363-5","volume":"106","author":"MS Cappell","year":"1999","unstructured":"Cappell, M. S. & Iacovone, F. M. J. Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction. Am. J. Med. 106(1), 29\u201335 (1999).","journal-title":"Am. J. Med."},{"issue":"3","key":"9911_CR36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9343(99)80159-4","volume":"99","author":"JG Lee","year":"1995","unstructured":"Lee, J. G., Krucoff, M. W. & Brazer, S. R. Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: Prevalence and risk factors. Am. J. Med. 99(3), 270\u2013275 (1995).","journal-title":"Am. J. Med."},{"issue":"10","key":"9911_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/SMJ.0000000000000001","volume":"106","author":"RG Lim","year":"2013","unstructured":"Lim, R. G. et al. Endoscopy after acute myocardial infarction: An evaluation of safety. South Med. J. 106(10), 545\u2013549 (2013).","journal-title":"South Med. J."},{"issue":"5","key":"9911_CR38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.mcg.0000225624.91791.fa","volume":"41","author":"BJ Spier","year":"2007","unstructured":"Spier, B. J. et al. Safety of endoscopy after myocardial infarction based on cardiovascular risk categories: A retrospective analysis of 135 patients at a tertiary referral medical center. J. Clin. Gastroenterol. 41(5), 462\u2013467 (2007).","journal-title":"J. Clin. Gastroenterol."},{"issue":"5","key":"9911_CR39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5603\/CJ.2012.0083","volume":"19","author":"M Cena","year":"2012","unstructured":"Cena, M. et al. Safety of endoscopic procedures after acute myocardial infarction: A systematic review. Cardiol. J. 19(5), 447\u2013452 (2012).","journal-title":"Cardiol. J."},{"issue":"3","key":"9911_CR40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.14309\/ajg.0000000000000528","volume":"115","author":"GR Hoffman","year":"2020","unstructured":"Hoffman, G. R. et al. Safety of endoscopy for hospitalized patients with acute myocardial infarction: A national analysis. Am. J. Gastroenterol. 115(3), 376\u2013800 (2020).","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"9911_CR41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.recesp.2020.12.024","volume":"74","author":"JP Collet","year":"2021","unstructured":"Collet, J. P. et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev. Esp. Cardiol. (Engl Ed) 74(6), 544 (2021).","journal-title":"Rev. Esp. Cardiol. (Engl Ed)"},{"issue":"5","key":"9911_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"DJ Kumbhani","year":"2021","unstructured":"Kumbhani, D. J. et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: A report of the American College of Cardiology solution set oversight committee. J. Am. Coll. Cardiol. 77(5), 629\u2013658 (2021).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09911-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09911-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09911-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:09:55Z","timestamp":1669320595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09911-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9911"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09911-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1119663\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5798"}}